Dyne Therapeutics Inc (DYN): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 03.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 39,4 US Dollar | 7 | 6 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 186.746.431 | 14,7 | 8,42 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Dyne Therapeutics Inc
Mitarbeiter 289
Handelsplatz NASDAQ
Ticker Symbol DYN
IPO Datum 2020-09-17
Adresse 1560 Trapelo Road, Waltham, MA, United States, 02451
Webseite https://www.dyne-tx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. John G. Cox M.B.A. | CEO, President & Director |
| 2 | Mr. Erick J. Lucera C.F.A., CPA | CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer |
| 3 | Dr. Oxana Beskrovnaya Ph.D. | Chief Innovation Officer |
| 4 | Ms. Johanna Friedl-Naderer | Chief Commercial Officer |
| 5 | Dr. Douglas Kerr M.B.A., M.D., Ph.D. | Chief Medical Officer |
| 6 | Dr. Axel Wiest | Senior VP and Head of Portfolio Strategy & Operations |
| 7 | Dr. Rajesh Manchanda Ph.D. | Chief Technical Officer |
| 8 | Mr. James P. Bilotta M.B.A. | Chief Digital & Information Officer |
| 9 | Mr. Alessandro Martuscelli | Chief Legal Officer |
| 10 | Ms. Lucia Celona | Chief Human Resource Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | T. Rowe Price Investment Management,Inc. | 16,49% | 0,77 Mrd. USD |
| 2 | HHG PLC | 7,31% | 0,34 Mrd. USD |
| 3 | BlackRock Inc | 6,27% | 0,29 Mrd. USD |
| 4 | FMR Inc | 4,77% | 0,22 Mrd. USD |
| 5 | Atlas Venture Life Science Advisors, LLC | 3,64% | 0,17 Mrd. USD |
| 6 | Orbis Allan Gray Ltd | 3,62% | 0,17 Mrd. USD |
| 7 | State Street Corp | 3,56% | 0,17 Mrd. USD |
| 8 | Vanguard Capital Management, LLC | 3,43% | 0,16 Mrd. USD |
| 9 | Perceptive Advisors LLC | 2,50% | 0,12 Mrd. USD |
| 10 | FCPM III SERVICES BV | 2,49% | 0,12 Mrd. USD |
| 11 | TCG Crossover Management, LLC | 2,47% | 0,12 Mrd. USD |
| 12 | Vanguard Portfolio Management, LLC | 2,23% | 0,10 Mrd. USD |
| 13 | Vestal Point Capital LP | 2,14% | 0,10 Mrd. USD |
| 14 | Geode Capital Management, LLC | 1,88% | 0,09 Mrd. USD |
| 15 | JPMorgan Chase & Co | 1,74% | 0,08 Mrd. USD |
| 16 | Armistice Capital, LLC | 1,70% | 0,08 Mrd. USD |
| 17 | Frazier Life Sciences Management, L.P. | 1,69% | 0,08 Mrd. USD |
| 18 | Orbimed Advisors LLC | 1,56% | 0,07 Mrd. USD |
| 19 | Logos Global Management LP | 1,37% | 0,06 Mrd. USD |
| 20 | T. Rowe Price Associates, Inc. | 1,25% | 0,06 Mrd. USD |